Can Proteomics Aid in Personalized Cancer Therapy?
Yes, proteomics is instrumental in advancing personalized cancer therapy. By profiling the proteome of an individual patient's tumor, clinicians can identify specific protein targets and tailor treatments accordingly. This approach ensures that patients receive the most effective therapies with the least side effects. For instance, the identification of EGFR mutations through proteomic analysis can guide the use of EGFR inhibitors in treating certain types of lung cancer.
